As mentioned above, ROS induced by BCR-ABL causes chronic oxidative DNA damage and stimulates homologous recombination repair, leading to a high gene mutation rate, which is also one of the important reasons for the emergence of imatinib resistance in leukemia [58, 59]. This evidence concerns the gene ABL1 and leukemia.